PHA-680632 50mg 50mg | Purity Not Available
Adooq Bioscience
PHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.
More Information Supplier PagePHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.
More Information Supplier PagePHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.
More Information Supplier PagePHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.
More Information Supplier PagePHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.
More Information Supplier PagePHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.
More Information Supplier PageDanusertib (PHA-739358) is a novel combined pan-Aurora kinases and third generation Bcr-Abl tyrosine kinase inhibitor
More Information Supplier PageDanusertib (PHA-739358) is a novel combined pan-Aurora kinases and third generation Bcr-Abl tyrosine kinase inhibitor
More Information Supplier PagePhenoxybenzamine is a cell-permeable, non-specific, irreversible ??-adrenergic (AR) antagonist that also acts as an CaM inhibitor.
More Information Supplier PagePhenformin hydrochloride is a hydrochloride salt of phenformin from the biguanide drug class that displays anti-diabetic activity.
More Information Supplier Page